King's College London, London (United Kingdom of Great Britain & Northern Ireland)
3
presentations
0
follower
7
more
presentations
in this session
The use of warfarin as part of antithrombotic strategy after transcutaneous aortic valve replacement is not associated with better medium-term outcomes